Immune system may mount an attack in Parkinson’s disease
T cells may play an important role in Parkinson’s disease (PD), according to a new study...
List view / Grid view
News
Imaging technique overturns longstanding DNA folding model
Researchers have developed an electron microscopy technique that enables the 3D structure and packing of DNA to be visualised inside the cell nucleus of intact cells.
Novel perspectives on anti-amyloid treatment for the prevention of Alzheimer’s
A collaboration between Prof LucĂa Chávez-GutiĂ©rrez and Prof Bart De Strooper of VIB-KU Leuven has revealed the molecular basis of the hereditary form of Alzheimer’s disease that strikes early in life.
Biomarkers show promise as Alzheimer’s diagnostic tool
Physical biomarkers have been discovered that may help diagnose the changes to proteins found in the spinal fluid and blood of Alzheimer's patients...
VRC01 antibody may prolong time to HIV viral rebound
A study has shown the infusion of a broadly neutralising antibody (VRC01) in virally suppressed volunteers associated with a modestly delayed rebound of HIV...
Researchers use CRISPR-Cas9 to target retinal angiogenesis.
Researchers have used CRISPR-Cas9 to target retinal angiogenesis via an adeno-associated virus to deliver genomic edits to target vascular endothelial cell growth factor...
US Phase 2 trial to test targeted drugs in paediatric tumours
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...
New therapeutic approach for ovarian cancer identified
Scientists discover, a potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer...
Study identifies new brain death pathway in Alzheimer’s disease
Evidence that the activation of a biological pathway necroptosis is closely linked with Alzheimer's...
Immune cells the missing ingredient in new bladder cancer treatment
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer...
Orphan drug market to double as Pharma rethinks business model
Market intelligence suggests pharma is being forced to shift focus towards niche patient populations and orphan diseases ...
Polyphor achieves first milestone from Wellcome for antibiotic development
Polyphor achieves first milestone from Wellcome Trust for the development of antibiotics against Gram-negative multi drug - resistant pathogens...
BenevolentAI hires new head of Cheminformatics from The Institute of Cancer Research
BenevolentAI announced today it has hired Dr Nathan Brown, as its new Head of Cheminformatics following the promotion of Mark Davies...
Takeda launches contract R&D firm AXCELEAD
Takeda has launched a contract research and development company, AXCELEAD, at its Shonan Research Centre.
New tool found to boost immunity in fight against cancer and infections
Researchers have developed a new tools to increase immune response against cancer and infections...
